BioNTech
BNTX
BNTX
285 hedge funds and large institutions have $3.78B invested in BioNTech in 2024 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 94 increasing their positions, 88 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
285
Holders Change
+6
Holders Change %
+2.15%
% of All Funds
4.13%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
50
Increased
94
Reduced
88
Closed
42
Calls
$167M
Puts
$165M
Net Calls
+$1.87M
Net Calls Change
-$8.97M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$77M |
| 2 |
DM
Deerfield Management
New York
|
$52.5M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$44.2M |
| 4 |
BlackRock
New York
|
$176M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
$17.5M |
Top Sellers
| 1 |
Temasek Holdings
Singapore
|
$316M |
| 2 |
UBS AM
Chicago,
Illinois
|
$19.7M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
$0 |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$771M |
| 5 |
Morgan Stanley
New York
|
$100M |
